Αρχική World News EMA Recommends Granting a Marketing Authorisation for Accordpharma Enzalutamide World News EMA Recommends Granting a Marketing Authorisation for Accordpharma Enzalutamide Από Ogkologos - 5 Δεκεμβρίου, 2025 358 0 Facebook Twitter Google+ Pinterest WhatsApp It is a generic and hybrid of Xtandi, which has been authorised in the EU since 2013 Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR From Scan to Scan: The Challenges of Living with Metastatic Cancer 15 Οκτωβρίου, 2021 Sound Waves Can Target Lymph Nodes And Help Kill Breast Cancer... 22 Νοεμβρίου, 2019 ¿Qué son los biosimilares para el tratamiento del cáncer? 30 Νοεμβρίου, 2021 Pembrolizumab Provides First-Ever Overall Survival Improvement in Kidney Cancer 21 Μαΐου, 2024 Φόρτωση περισσοτέρων HOT NEWS Durvalumab Extends Lives of People with Early-Stage Small Cell Lung Cancer Cómo mi diagnóstico de cáncer a los 17 años cambió mi... Not Old Enough for Breast Cancer, She Demanded a Mammogram Anyway... Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause...